Want to see IN:XPROINDIA full AI Analyst Report?
XPRO India Limited (XPROINDIA) AI Stock Analysis
XPRO India Limited
(NSE:XPROINDIA)
Mixed financial performance with balance sheet strengths offset by cash flow weaknesses and income volatility weighs on the score; poor valuation due to high P/E adds downside risk, while neutral-to-positive technicals provide some support.
XPRO India Limited (XPROINDIA) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 23.70B
- Dividend Yield
- 0.20%
- Average Volume (3M)
- 9,012
- Price to Earnings (P/E)
- 71.9
- Beta (1Y)
- 1.25
- Revenue Growth
- -1.23%
- EPS Growth
- 66.26%
- Country
- India
- Employees
- 658
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
XPRO India Limited Business Overview & Revenue Model
Company Description
Xpro India Limited processes and sells polymers primarily in India. The company offers dielectric films for applications comprising power transmission and distribution, motor run, power film/electronic, magnetic lighting ballast, microwave oven, low...
How the Company Makes Money
XPRO India Limited primarily makes money by manufacturing and selling polymer-based packaging and industrial material products to business customers. Its revenue model is centered on (1) product sales from its manufacturing operations, where earnings...
XPRO India Limited Financial Statement Overview
Summary
Mixed financials with solid revenue growth and strong balance sheet equity expansion, but offset by income volatility, projected declines, and negative free cash flow in later years, indicating sustainability risks.
Income Statement
55NeutralBalance Sheet
75PositiveCash Flow
45Neutral| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.35B | 5.05B | 5.35B | 4.65B | 5.11B | 4.72B |
| Gross Profit | 1.22B | 1.05B | 1.08B | 1.48B | 1.61B | 1.22B |
| EBITDA | 687.65M | 474.16M | 691.21M | 763.08M | 769.51M | 647.19M |
| Net Income | 326.60M | 192.34M | 379.97M | 438.79M | 453.64M | 449.32M |
Balance Sheet | ||||||
| Total Assets | 0 | 12.18B | 9.93B | 6.77B | 3.40B | 3.35B |
| Cash, Cash Equivalents and Short-Term Investments | 2.98B | 2.99B | 2.61B | 2.05B | 264.11M | 193.63M |
| Total Debt | 0 | 3.25B | 2.69B | 390.00M | 386.82M | 898.87M |
| Total Liabilities | -7.98B | 4.20B | 3.82B | 1.17B | 1.07B | 1.63B |
| Stockholders Equity | 7.98B | 7.60B | 6.10B | 5.61B | 2.34B | 1.72B |
Cash Flow | ||||||
| Free Cash Flow | -660.36M | -1.14B | -2.62B | 58.15M | 465.36M | 420.77M |
| Operating Cash Flow | -20.19M | 270.46M | 252.35M | 439.79M | 828.55M | 486.21M |
| Investing Cash Flow | -1.41B | -1.75B | -1.31B | -3.20B | -582.75M | -104.59M |
| Financing Cash Flow | 806.86M | 1.58B | 2.08B | 2.78B | -431.40M | -211.58M |
XPRO India Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:XPROINDIA, the sentiment is Negative. The current price of 1011.75 is below the 20-day moving average (MA) of 1038.18, below the 50-day MA of 1143.92, and below the 200-day MA of 1115.91, indicating a bearish trend. The MACD of -45.87 indicates Negative momentum. The RSI at 39.62 is Neutral, neither overbought nor oversold. The STOCH value of 39.06 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:XPROINDIA.
XPRO India Limited Peers Comparison
Overall Rating
IN:FCL69Neutral
IN:NOCIL67Neutral
IN:ROSSARI65Neutral
IN:TATVA55Neutral
IN:XPROINDIA53Neutral
IN:NEOGEN46Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 69Neutral | INR 56.58B | 40.33 | ― | 0.27% | 91.44% | 19.67% | |
| 67Neutral | INR 22.92B | 34.63 | ― | 1.09% | 0.96% | -28.98% | |
| 65Neutral | INR 22.12B | 14.48 | ― | 0.13% | 19.76% | 11.74% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 55Neutral | INR 38.49B | 61.11 | ― | 0.12% | 49.69% | 254.75% | |
| 53Neutral | INR 23.75B | 71.87 | ― | 0.20% | -1.23% | 66.26% | |
| 46Neutral | INR 65.47B | 163.88 | ― | 0.05% | 18.00% | 3.85% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:XPROINDIA | XPRO India Limited | 1011.75 | -82.94 | -7.58% | |
| IN:FCL | Fineotex Chemical Limited | 48.59 | 16.55 | 51.67% | |
| IN:NEOGEN | Neogen Chemicals Ltd. | 2179.35 | 717.56 | 49.09% | |
| IN:NOCIL | NOCIL Limited | 137.20 | -42.32 | -23.58% | |
| IN:ROSSARI | Rossari Biotech Ltd | 399.25 | -242.58 | -37.79% | |
| IN:TATVA | Tatva Chintan Pharma Chem Limited | 1645.45 | 235.40 | 16.69% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 05, 2026